Pluristem Advances its Multinational Phase III …

← Back to document page

Pluristem Advances its Multinational Phase III Critical Limb Ischemia Study, Targeting Initiation at 40 Active Sites by the End of 2017 • Austria’s regulatory health agency clears CLI study and joins the U.S., U.K., and Germany

  Phases, Study, Advance, Multinational, Initiation, Ischemia, Limb, Targeting, Pluristem advances its multinational phase, Pluristem, Limb ischemia study, Targeting initiation